This was a real winner yesterday and today is going to be the same, already up 12% pre market, we think there should be continuation in this name for days to come.
Outlook Therapeutics started at outperform with $12 stock price target at Oppenheimer
OUTLOOK THERAPEUTICS INC.
Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm...
Hello Successful Traders,
The stock (OTLK) manifests the opportunity of a bullish upside, considering the previous con-test (and infiltration) for an all time low. A correction is a viable observation, considering the current reverse stop split (limiting the amount of stocks prevalent) there may increased demand (resulting in price spike). Await for confirmation...